A new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) than the current accepted standard of care, according to results announced...

The coronavirus disease 2019 (COVID-19) pandemic continues to ravage worldwide, infecting over 118.15 million people. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infection...

In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has generated deep, sustained remissions in patients who had relapsed from several previous therapies, an international clinical...

A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins...